Correction: Secondary autoimmune and inflammatory diseases after allogeneic hematopoietic stem cell transplantation: a retrospective study from the EBMT transplant complications and autoimmune diseases working parties - Summary - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Amendment: Post-Transplant Autoimmune and Inflammatory Disorders Following Allogeneic Hematopoietic Stem Cell Transplantation: A Retrospective Analysis by the EBMT Working Groups on Transplant Complications and Autoimmune Conditions

  • By

  • Arsene Mekinian

  • Artem Oganesyan

  • Zinaida Perić

  • Myriam Labopin

  • Urpu Salmenniemi

  • José Antonio Pérez Simón

  • Anke Verlinden

  • Ioanna Sakellari

  • Mohsen Alzahrani

  • Massimo Martino

  • Frédéric Baron

  • John A. Snowden

  • Hakan Ozdogu

  • Alexander Kulagin

  • Edgar Jost

  • Anna Torrent

  • Fabio Benedetti

  • Anna De Becker

  • Sylvie François

  • Montserrat Rovira

  • Hans Christian Reinhardt

  • Alessandra Biffi

  • Mark Ringhoffer

  • Pascal Ambron

  • Jose Luis López Lorenzo

  • Nabil Yafour

  • Alexandre Galvagni

  • Manuela Badoglio

  • Ivan Moiseev

  • Tobias Alexander

  • Mohamad Mohty

  • Olivier Fain

  • Raffaella Greco

  • Olaf Penack

  • September 25, 2026

Share

Objective:

To correct the title of the article regarding autoimmune and inflammatory diseases post-allogeneic hematopoietic stem cell transplantation.

Approach:
  • Correction: The title correction clarifies that the retrospective study is attributed to the EBMT Complications Working Party (CWP) rather than the broader EBMT working groups.
Key Findings:
  • The original title inaccurately referred to the EBMT transplant complications and autoimmune diseases working parties.
Interpretation:

The correction ensures accurate attribution of the study to the appropriate EBMT working party.

Conclusion:

The article has been corrected to reflect the accurate title and attribution.

Sources:

Original Source(s)

Correction: Secondary autoimmune and inflammatory diseases after allogeneic hematopoietic stem cell transplantation: a retrospective study from the EBMT transplant complications and autoimmune diseases working parties

  • by Arsene Mekinian, Artem Oganesyan, Zinaida Perić, Myriam Labopin, Urpu Salmenniemi, José Antonio Pérez Simón, Anke Verlinden, Ioanna Sakellari, Mohsen Alzahrani, Massimo Martino, Frédéric Baron, John A. Snowden, Hakan Ozdogu, Alexander Kulagin, Edgar Jost, Anna Torrent, Fabio Benedetti, Anna De Becker, Sylvie François, Montserrat Rovira, Hans Christian Reinhardt, Alessandra Biffi, Mark Ringhoffer, Pascal Ambron, Jose Luis López Lorenzo, Nabil Yafour, Alexandre Galvagni, Manuela Badoglio, Ivan Moiseev, Tobias Alexander, Mohamad Mohty, Olivier Fain, Raffaella Greco, Olaf Penack

  • September 25, 2026

Related Content

Bringing CAR T Closer to Home

CAR T Vision aims to widen access to cell therapy by expanding community-based delivery, easing operational barriers, and building sustainable funding models

  • October 13, 2026

  • 8 min
Immune and cellular determinants of response to HMA-venetoclax regimens in acute myeloid leukemia

Diagnostic Value of Skin Biopsy in Fatal Histoplasmosis-Associated Hemophagocytic Lymphohistiocytosis: A Case Report